Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma.
Bousquet Mur E, Bernardo S, Papon L, Mancini M, Fabbrizio E, Goussard M, Ferrer I, Giry A, Quantin X, Pujol JL, Calvayrac O, Moll HP, Glasson Y, Pirot N, Turtoi A, Cañamero M, Wong KK, Yarden Y, Casanova E, Soria JC, Colinge J, Siebel CW, Mazieres J, Favre G, Paz-Ares L, Maraver A.
Bousquet Mur E, et al. Among authors: maraver a.
J Clin Invest. 2020 Feb 3;130(2):612-624. doi: 10.1172/JCI126896.
J Clin Invest. 2020.
PMID: 31671073
Free PMC article.